A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer ...

A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the ...

Menopausal hormone therapy (MHT) does not raise breast cancer risk in women with breast cancer gene mutations, while estrogen only MHT leads to reduced risk.

Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell death—to survive treatment. Instead of dying, these “persister cells” ...

NEW YORK (Reuters Health) - Women carrying BRCA mutations tied to breast and ovarian cancer may hit menopause a few years earlier than other women, according to a new study. Doctors already discuss ...

One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...

Indoor tanning is associated with markedly higher mutation burdens and cancer-driving genetic changes in melanocytes taken ...

Researchers discovered that tanning beds cause widespread, mutation-laden DNA damage across almost all skin, explaining the ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

Cancer has long been treated as a mass of rogue cells, but the real power lies in the intricate communication networks ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

REUTERS - Women who carry the BRCA mutations tied to breast and ovarian cancer may hit menopause a few years earlier than other women, according to a U.S. study of nearly a thousand women. Doctors ...